Bulgaria’s caretaker Cabinet approved on September 16 the purchase of 10 000 doses of the Sanofi – GlaxoSmithKline vaccine against Covid-19, a government information service statement said.
The purchase is to be made in accordance with the agreement between the European Commission and the pharmaceutical manufacturers on the development, production, purchase and supply of Covid-19 vaccines for EU countries, the statement said.
The vaccine is a single-dose one that is not expected at this stage to be used for primary immunisation, but for those who have undergone the disease or have been vaccinated with another vaccine.
It is an alternative to vaccination in people with contraindications to other types of vaccines.
The vaccine is stored at temperatures between two and eight degrees Celsius.
The expected delivery times are in the first half of 2022, the statement said.
With the country’s participation in the agreement, a wide portfolio of vaccines against Covid-19 will be provided, the statement said.
(Photo: EC Audiovisual Service)
For the rest of The Sofia Globe’s continuing coverage of the Covid-19 situation, please click here.
The Sofia Globe’s coverage of the Covid-19 situation in Bulgaria is supported by the Embassies of Switzerland and Finland.
Please support independent journalism by clicking on the orange button below. For as little as three euro a month or the equivalent in other currencies, you can support The Sofia Globe via patreon.com: